ResMed Inc. Stock BOERSE MUENCHEN
Stocks
RMEA
AU000000RMD6
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.40 EUR | 0.00% |
|
-0.61% | -20.39% |
| 06-22 | KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating | MT |
| 06-17 | ResMed Shares Fall After Morgan Stanley Downgrade | MT |
| Market Cap | 27.22B 23.91B 22.03B 20.62B 38.64B 2,578B 39.29B 265B 102B 1,265B 102B 99.97B 4,397B | P/E 2026 * |
18x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 26.36B 23.15B 21.34B 19.97B 37.42B 2,497B 38.05B 256B 99.17B 1,225B 98.94B 96.81B 4,258B | EV / Sales 2026 * |
4.66x | EV / Sales 2027 * | 4.21x |
| Free-Float |
75.61% | Yield 2026 * |
1.27% | Yield 2027 * | 1.41% |
Last Transcript: ResMed Inc.
| 1 week | -0.61% | ||
| Current month | -5.20% | ||
| 1 month | -7.87% | ||
| 3 months | -15.46% | ||
| 6 months | -20.39% | ||
| Current year | -20.39% |
| 1 week | 16.4 |  | 17.1 |
| 1 month | 15.8 | | 17.7 |
| 3 years | 13.1 | | 24.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 2013-02-28 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 2026-05-03 |
Jim Ellis
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 53 | 2023-01-24 |
Peter Farrell
CHM | Chairman | 83 | 1989-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.61% | -24.07% | -18.00% | 27.22B | |
| +1.15% | -0.92% | +17.96% | -11.16% | 172B | |
| +0.06% | -3.21% | -20.85% | +23.07% | 143B | |
| +0.44% | -1.18% | -8.87% | -24.29% | 126B | |
| +2.86% | -2.48% | -54.99% | -16.54% | 65.89B | |
| +1.25% | +0.78% | +17.77% | -4.80% | 49.45B | |
| +0.06% | -1.26% | -25.33% | -31.86% | 44.05B | |
| +0.14% | -3.00% | +9.61% | +6.73% | 35.72B | |
| -0.29% | -0.16% | +4.25% | +37.24% | 35.18B | |
| +5.08% | -1.61% | -10.61% | -20.56% | 27.58B | |
| Average | +0.82% | -2.49% | -9.51% | -6.02% | 77.68B | |
| Weighted average by Cap. | +0.47% | -2.43% | -7.31% | -5.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.96B 4.57B 4.28B 8.02B 535B 8.16B 54.93B 21.26B 263B 21.21B 20.76B 913B | 6.1B 5.36B 4.93B 4.62B 8.65B 577B 8.8B 59.25B 22.94B 283B 22.88B 22.39B 985B |
| Net income | 1.55B 1.36B 1.25B 1.17B 2.2B 147B 2.24B 15.05B 5.83B 71.98B 5.81B 5.69B 250B | 1.7B 1.49B 1.38B 1.29B 2.41B 161B 2.46B 16.53B 6.4B 79.04B 6.38B 6.25B 275B |
| Net Debt | -859M -755M -695M -651M -1.22B -81.39B -1.24B -8.35B -3.23B -39.93B -3.23B -3.16B -139B | -1.58B -1.39B -1.28B -1.2B -2.24B -149B -2.28B -15.33B -5.94B -73.33B -5.92B -5.79B -255B |
| Date | Price | Change |
|---|---|---|
| 26-06-23 | €16.40 | 0.00% |
| 26-06-22 | €16.40 | 0.00% |
| 26-06-19 | €16.40 | 0.00% |
| 26-06-18 | €16.40 | -1.20% |
| 26-06-17 | €16.60 | -2.92% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- RMEA Stock
Select your edition
All financial news and data tailored to specific country editions
